78720 Federal Register / Vol. 75, No. 241 / Thursday, December 16, 2010 / Notices 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting). 

Contact Person: Rajiv Kumar, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4122, 

MSC 7802, Bethesda, MD 20892, 301–435– 

1212. kumarra@csr.nih.gov. 

Name of Committee: Digestive, Kidney and 

Urological Systems Integrated Review Group. 

Clinical, Integrative and Molecular 

Gastroenterology Study Section. 

Date: January 31–February 1, 2011. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Mushtaq A. Khan, DVM, 

PhD, Chief, Digestive, Kidney and Urological 

Systems, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 2176, MSC 7818, Bethesda, MD 

20892. 301–435–1778. khanm@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: December 10, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–31601 Filed 12–15–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Library of Medicine; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors, National 

Center for Biotechnology Information. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for review, discussion, and evaluation of 

individual intramural programs and 

projects conducted by the National 

Library of Medicine, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors, National Center for 

Biotechnology Information. 

Date: April 12, 2011. 

Open: 8:30 a.m. to 12 p.m. 

Agenda: Program Discussion. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20892. 

Closed: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20892. 

Open: 2 p.m. to 3 p.m 

Agenda: Program Discussion. 

Place: National Library of Medicine, 

Building 38, 2nd Floor, Board Room, 8600 

Rockville Pike, Bethesda, MD 20892. 

Contact Person: David J. Lipman, MD, 

Director, National Center of Biotechnology 

Information, National Library of Medicine, 

Department of Health and Human Services, 

Building 38A, Room 8N805, Bethesda, MD 

20892. 301–435–5985, dlipman@mail.nih.

gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

(Catalogue of Federal Domestic Assistance 

Program No. 93.879, Medical Library 

Assistance, National Institutes of Health, 

HHS). 

Dated: December 10, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–31623 Filed 12–15–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Proposed Project: 2011–2014 National 

Survey on Drug Use and Health: 

Methodological Field Tests (OMB No. 

0930–0290)–Revision 

The National Survey on Drug Use and 

Health (NSDUH) is a survey of the 

civilian, non-institutionalized 

population of the United States 12 years 

old and older. The data are used to 

determine the prevalence of use of 

tobacco products, alcohol, illicit 

substances, and illicit use of 

prescription drugs. The results are used 

by SAMHSA, ONDCP, Federal 

Government agencies, and other 

organizations and researchers to 

establish policy, direct program 

activities, and better allocate resources. 

In March 2008, SAMHSA received a 

3-year renewal of its generic clearance 

for methodological field tests. This will 

be a request for another renewal of the 

generic approval to continue 

methodological tests over the next 3 

years, with conditions similar to the 

previous clearance. These 

methodological tests will continue to be 

designed to examine the feasibility, 

quality, and efficiency of new 

procedures or revisions to existing 

survey protocol. Specifically, the tests 

will measure the reliability and validity 

of certain questionnaire sections and 

items through multiple measurements 

on a set of respondents; assess new 

methods for gaining cooperation and 

participation of respondents with the 

goal of increasing response and 

decreasing potential bias in the survey 

estimates; and assess the impact of new 

sampling techniques and technologies 

on respondent behavior and reporting. 

Research will involve focus groups, 

cognitive laboratory testing, field tests, 

and customer surveys. 

The next wave of methodological tests 

will continue to examine ways to 

increase data quality, lower operating 

costs, and gain a better understanding of 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 241 / Thursday, December 16, 2010 / Notices 78721 

sources and effects of nonsampling error 

on the NSDUH estimates. Particular 

attention will be given to minimizing 

the impact of design changes so that 

survey data continue to remain 

comparable over time. If these tests 

provide successful results, current 

procedures or data collection 

instruments may be revised. 

The number of respondents to be 

included in each field test will vary, 

depending on the nature of the subject 

being tested and the target population. 

However, the total estimated response 

burden is 8,251 hours. The exact 

number of subjects and burden hours for 

each test are unknown at this time, but 

will be clearly outlined in each 

individual submission. The table below, 

however, describes the anticipated 

burden for each of the major testing 

activities for which generic approval is 

being tested. 

ESTIMATED BURDEN FOR NSDUH METHODOLOGICAL FIELD TESTS

Activity Number of 

respondents 

Responses 

per 

respondent 

Total number 

of responses 

Average 

burden per 

response (hrs.) 

Total burden 

(hrs.) 

a. Focus Groups ................................................................ 270 1 270 2 .0 540 

b. Cognitive laboratory testing ........................................... 200 1 200 1 .0 200 

c. Field Tests ..................................................................... 6,600 1 6,600 1 .0 6,600 

d. Customer Satisfaction Surveys ..................................... 300 1 300 0 .25 75 

Household screening for c ................................................. 8,910 1 8,910 0 .083 740 

Screening Verification for c ................................................ 445 1 445 0 .067 30 

Interview Verification for c ................................................. 990 1 990 0 .067 66 

Total ............................................................................ 17,715 ........................ 17,715 .......................... 8,251 

Annual Average (Total divided by 3 years) ....................... 5,905 ........................ 5,905 .......................... 2,750 

Written comments and 

recommendations concerning the 

proposed information collection should 

be sent by January 18, 2011 to: 

SAMHSA Desk Officer, Human 

Resources and Housing Branch, Office 

of Management and Budget, New 

Executive Office Building, Room 10235, 

Washington, DC 20503; due to potential 

delays in OMB’s receipt and processing 

of mail sent through the U.S. Postal 

Service, respondents are encouraged to 

submit comments by fax to: 202–395– 

7285. 

Dated: December 1, 2010. 

Elaine Parry, 

Director, Office of Management, Technology 

and Operations. 

[FR Doc. 2010–31585 Filed 12–15–10; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Substance Abuse and 

Mental Health Services Administration 

(SAMHSA) will publish a summary of 

information collection requests under 

OMB review, in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

documents, call the SAMHSA Reports 

Clearance Officer on (240) 276–1243. 

Project: Screening, Brief Intervention, 

Brief Treatment and Referral to 

Treatment (SBIRT) Cross-Site 

Evaluation—New 

SAMHSA is conducting a cross-site 

external evaluation of the impact of 

programs of screening, brief 

intervention (BI), brief treatment (BT) 

and referral to treatment on patients 

presenting at various health care 

delivery units with a continuum of 

severity of substance use. SAMHSA’s 

SBIRT program is a cooperative 

agreement grant program designed to 

help States and Tribal Councils expand 

the continuum of care available for 

substance misuse and use disorders. 

The program includes screening, brief 

intervention, brief treatment and 

referrals to treatment for persons at risk 

for dependence on alcohol or drugs. The 

cross-site evaluation will provide a 

comprehensive assessment of the effects 

of SBIRT on patient outcomes, 

performance site practices, and 

treatment systems. This information 

will allow SAMHSA to determine the 

extent to which SBIRT has met its 

objectives of implementing a 

comprehensive system of identification 

and care to meet the needs of 

individuals at all points along the 

substance use continuum. 

A paper and pencil survey will be 

administered to practitioners in sites 

where SBIRT services are being 

delivered. The practitioner survey is 

designed to evaluate the 

implementation of proposed SBIRT 

models by measuring their penetration 

and practitioners’ willingness to adopt. 

Furthermore, the survey will document 

moderating factors related to 

practitioner and health care delivery 

unit characteristics. 

The 93 question practitioner survey 

includes collection of demographic 

information as well as questions that 

attempt to assess barriers to 

implementation encountered by the 

practitioners and to gauge the 

effectiveness of the training they 

received. These measures were 

developed and used by Babor et al. 

(2005) in their comparable study 

comparing different implementation 

strategies for primary care screening and 

brief intervention programs for 

hazardous and harmful drinkers. The 

practitioner survey also includes an 

instrument developed by Panzano and 

Roth (2006) to measures an 

organization’s willingness to adopt new 

innovative practices. 

TOTAL BURDEN HOURS FOR THE CROSS-SITE PATIENT SURVEY

Instrument/activity Number of 

respondents 

Responses 

per 

respondent 

Hours per 

response 

Total burden 

hours Hourly wage 

Total 

respondent 

cost a

Practitioner Survey ................................... 1,075 1 .30 322.5 $32 $10,320 


srobinson on DSKHWCL6B1PROD with NOTICES